Abstract:The mechanism of SENPs involved in human oxidative stress‐related diseases. Oxidative stress is employed to depict a series of responses detrimental to normal cellular functions resulting from an imbalance between intracellular oxidants, mainly reactive oxygen species and antioxidant defenses. Oxidative stress often contributes to the development of various diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. In this process, the relationship between small ubiquitin‐like modifier (SUMO) and oxidative stress has garnered significant attention, with its posttranslational modification (PTM) frequently serving as a marker of oxidative stress status. Sentrin/SUMO‐specific proteases (SENPs), affected by alternative splicing, PTMs such as phosphorylation and ubiquitination, and various protein interactions, are crucial molecules in the SUMO process. The human SENP family has six members (SENP1–3, SENP5–7), which are classified into two categories based on sequence similarity, substrate specificity, and subcellular location. They have two core functions in the human body: first, by cleaving the precursor SUMO and exposing the C‐terminal glycine, they initiate the SUMO process; second, they can specifically recognize and dissociate SUMO proteins bound to substrates, a process known as deSUMOylation. However, the connection between deSUMOylation and oxidative stress remains a relatively unexplored area despite their strong association with oxidative diseases such as cancer and cardiovascular disease. This article aims to illustrate the significant contribution of SENPs to the oxidative stress pathway through deSUMOylation by reviewing their structure and classification, their roles in oxidative stress, and the changes in their expression and activity in several typical oxidative stress‐related diseases.

Exploring the Desumoylation Process of SENP1: a Study Combined MD Simulations with QM/MM Calculations on SENP1-SUMO1-RanGAP1.

Insights into the Allosteric Effect of SENP1 Q597A Mutation on the Hydrolytic Reaction of SUMO1 Via an Integrated Computational Study

The allosteric effect of the upper half of SENP1 contributes to its substrate selectivity for SUMO1 over SUMO2

Allosteric Activation of SENP1 by SUMO1 Β-Grasp Domain Involves a Dock-and-coalesce Mechanism

Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.

Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation

Role of Desumoylation in the Development of Prostate Cancer

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

Research progression on biologic function and effect of SUMO-specific proteinase

SUMO proteases: from cellular functions to disease

Activity Profiling of Human Desumoylating Enzymes (senps) with Synthetic Substrates Suggests an Unexpected Specificity of Two Newly Characterized Members of the Family

Development and Evaluation of a Highly Reliable Assay for SUMO-Specific Protease Inhibito R S

[Sumo-Specific Protease 1 and Cancer].

Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.

Mitochondrial SENP2 Regulates the Assembly of SDH Complex under Metabolic Stress

SUMO-specific proteases and isopeptidases of the SENP family at a glance

SENP1 is a Crucial Promotor for Hepatocellular Carcinoma Through Desumoylation of UBE2T

Identification of SENP1 Inhibitors Through in Silico Screening and Rational Drug Design.

Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction